MGRC swings back to profit in 2Q22

KUALA LUMPUR: Malaysian Genomics Resource Centre Bhd (MGRC) posted a net profit of RM1.01mil in the second quarter ended Dec 31, 2021 (2Q22) compared with a net loss of RM1.55mil in the same period a year prior.

The improved performance was due to its successful penetration into the distribution of immunotherapy and cell therapies, which contributed to a higher margin.